its last official publication was in 1997 141 and its activities are summarized in a superb book entitled Polycythemia Vera and the Myeloproliferative Disorders, edited by Louis Wasserman ...

Join Drs Tania Jain and Rachel Salit as they explore evolving definitions of remission, relapse monitoring, and ...

Patients with blood cancers like polycythemia vera, a kind of myeloproliferative neoplasm, may benefit in learning more about ...

Qiagen and Incyte have announced a master collaboration agreement to create a diagnostic panel to aid in the treatment of ...

WHAT ARE CHRONIC MYELOPROLIFERATIVE DISORDERS? Chronic myeloproliferative disorders are conditions where the bone marrow produces too many abnormal blood cells, affecting red or white blood cells ...

A new target for potential treatments for blast phase myeloproliferative neoplasm (BP-MPN), one of the most aggressive forms ...

Israel launches strikes on missile facilities in central Iran: air force Incyte (Nasdaq:INCY) today announced the first clinical data from two studies evaluating the safety, tolerability and efficacy ...

Panelists discuss how to select among the four available JAK inhibitors (Ruxolitinib, Fedratinib, Pacritinib, and Momelotinib) based on patient-specific factors such as anemia, thrombocytopenia, and ...

Strategic actions by Supernus, Teva, Incyte, and BioNTech highlight growing momentum in advancing clinical-stage therapies ...

QIAGEN N.V. QGEN recently announced a new global collaboration with Incyte INCY. The partnership enhances QIAGEN’s onco-hematology diagnostics pipeline and supports Incyte’s extensive portfolio in ...